Author:
Takeuchi Yoshinori,Kajiyama Kazuhiro,Ishiguro Chieko,Uyama Yoshiaki
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference31 articles.
1. Yan H, Chen JD, Zheng XY. Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia. Psychopharmacology. 2013;229:1–7.
2. Nagamine T. Olanzapine-induced elevation of serum triglyceride levels in a normal weight patient with schizophrenia. Intern Med. 2008;47:181–2.
3. Koro CE, Meyer JM. Atypical antipsychotic therapy and hyperlipidemia: a review. Essent Psychopharmacol. 2005;6:148–57.
4. Koro CE, Fedder DO, L’Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry. 2002;59:1021–6.
5. Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, editor. Goodman and Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill books; 2011. p. 877–908.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献